Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter 4-1BB (Utomilumab Biosimilar) Antikörper

Research Grade Reaktivität: Human ELISA, WB Wirt: Human Monoclonal unconjugated Recombinant Antibody
Produktnummer ABIN7538049
  • Target Alle 4-1BB (Utomilumab Biosimilar) Produkte
    4-1BB (Utomilumab Biosimilar)
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    Human
    Wirt
    • 1
    Human
    Expressionssystem
    Mammalian cells
    Klonalität
    • 1
    Monoklonal
    Konjugat
    • 1
    Dieser 4-1BB (Utomilumab Biosimilar) Antikörper ist unkonjugiert
    Applikation
    ELISA, Western Blotting (WB)
    Verwendungszweck
    Utomilumab Biosimilar - Anti-Human TNFRSF9 mAb - Research Grade
    Produktmerkmale
    Antibody Type: IgG2 kappa
    Aufreinigung
    Recombinant antibody expressed in mammalien cells and purified.
    Reinheit
    > 85%
    Güteklasse
    Research Grade
    Isotyp
    IgG2
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS pH 7.5
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    4°C for short term, -20°C for long term
  • Target
    4-1BB (Utomilumab Biosimilar)
    Abstract
    4-1BB (Utomilumab Biosimilar) Produkte
    Hintergrund
    Utomilumab is a monoclonal antibody that binds to 4-IBB protein (also known as CD137 protein). 4-IBB protein is a receptor found in different immune cells such as helper T-cells, killer T-cells and natural killer cells. 4-IBB/CD137 protein is a costimulatory receptor whose activation results in a series of events that leads to cytokine secretion and effector functions. Hence, targeting CD137 protein has been linked to antitumor immunity response and overall tumor reduction. Indeed, once utomilumab is injected in the bloodstream its specific binding to CD137 protein stimulates the immune cells which, as a result, enhances the immune response against tumors.
    CAS-Nummer
    1417318-27-4
Sie sind hier:
Kundenservice